Ruconest Disease Interactions
There is 1 disease interaction with Ruconest (conestat alfa).
Conestat alfa (applies to Ruconest) thromboembolism
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: History - Thrombotic/Thromboembolic Disorder, Thrombotic/Thromboembolic Disorder
Serious arterial and venous thromboembolic (TE) events have been reported at the recommended dose of plasma derived conestat alfa. Patients with risk factors such as, prior history of thrombosis might be at an increased risk. It is recommended to monitor patients with known risk factors for TE events during and after therapy administration.
Ruconest drug interactions
There are 48 drug interactions with Ruconest (conestat alfa).
More about Ruconest (conestat alfa)
- Ruconest consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.